The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query HTGM owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/HTGM"
Use Arkolith to show who owns HTGM, which funds added or reduced it, and which SEC filings prove each claim.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 8, 2023 | Barat Stephen | Senior VP of Therapeutics | Sell (S) | 888 | $710 |
| Mar 31, 2023 | Barat Stephen | Senior VP of Therapeutics | Tax withholding (F) | 52 | $140 |
| Dec 9, 2022 | Godlewski Laura Lee | SVP Finance & Administration | Grant (A) | 1K | $430 |
| Dec 9, 2022 | McMeans Shaun D | SVP, Finance & Admin. & CFO | Grant (A) | 1K | $430 |
| Dec 9, 2022 | Lubniewski John L | President & CEO, Director | Grant (A) | 1K | $430 |
| Dec 9, 2022 | Lawson Byron | SVP/Chief Commercial Officer | Grant (A) | 1K | $430 |
| Sep 15, 2022 | HANHAM ANN | Director | Grant (A) | 8K | $0 |
| Sep 15, 2022 | HARDISON DON M | Director | Grant (A) | 4K | $0 |
| Sep 15, 2022 | McCracken Lee R. | Director | Grant (A) | 4K | $0 |
| Sep 15, 2022 | GRIFFIN MICHELLE RENEE | Director | Grant (A) | 4K | $0 |
| Sep 15, 2022 | KIRITSY CHRISTOPHER P | Director | Grant (A) | 4K | $0 |
| Aug 18, 2022 | Dubensky Thomas W. | Director | Grant (A) | 8K | $0 |
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for HTGM. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.